By WIll Ferguson, College of Arts & Sciences Originally published in WSU News
WSU physicist Matthew McCluskey wasn’t trying to invent the next generation of material characterization microscopes, but when he couldn’t get the results he wanted from the best on the market, he improvised.
“Our new instrument could make a major impact in the $6.2 billion microscope market,” McCluskey said. “The business development advice and funding we received from the WSU Commercialization Gap Fund and the WSU Innovation Corps program were instrumental in our efforts to build a prototype and demonstrate the potential of this new technology.”
A Washington State University research team has successfully used a mild electric current to take on and beat drug-resistant bacterial infections, a technology that may eventually be used to treat chronic wound infections. » More …
A gene editing technology developed at WSU is being licensed to Genus plc, a global animal genetics company, to develop cattle that are more resistant to bovine respiratory disease (BRD).
“From domestication and selective breeding to today’s use of advanced biotechnology, the goal of all animal husbandry remains the same,” said Bryan Slinker, dean of WSU’s College of Veterinary Medicine. “The goal is to continue to optimize animal health and well-being and produce disease-free food animals. This work is another important step in ensuring we meet our responsibilities to animals as well as the world’s food supply, now and in the future.”
A discovery by Washington State University scientist Dan Rodgers and collaborator Paul Gregorevic could save millions of people suffering from muscle wasting disease.
The result of the team’s four-year project is a novel gene therapeutic approach. The work was published (http://stm.sciencemag.org/content/8/348/348ra98) July 20 in Science Translational Medicine, a journal of the American Association for the Advancement of Science.
“It occurs with chronic infection, muscular dystrophy, malnutrition and old age,” he said. “About half the people who die from cancer are actually dying from muscle wasting and there’s not one single therapy out there that addresses it. » More …
Since the Commercialization Gap Fund launched at Washington State University two years ago, 14 researchers have received funding to fill the gap between their discoveries and private investment. The Washington Research Foundation (WRF) has just invested up to $1 million for the next four years in the fund.
“We have been impressed with the diversity of innovations at WSU,” said Beth Etscheid, director of research commercialization at the WRF (http://www.wrfseattle.org/), which established the fund with WSU in 2014. » More …
A new licensing partnership between WSU and Excellims Corp. will improve chemical detection tools used to detect everything from dangerous chemicals to human disease.
“I am very happy to see our research achievements being implemented into a commercial instrument,” said Herbert Hill, a WSU Regents Professor in the Department of Chemistry who developed the licensed technology. “This will allow researchers in a variety of academic research and industrial research fields to have a more powerful tool based on ion mobility spectrometry.”